Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital

Antimicrob Agents Chemother. 2002 May;46(5):1577-80. doi: 10.1128/AAC.46.5.1577-1580.2002.

Abstract

Nineteen of 27 ceftazidime-resistant Enterobacter cloacae isolates from a neonatal intensive care unit in Thessaloniki, Greece, had genes coding for the novel extended-spectrum beta-lactamase IBC-1; 18 of those 19 harbored similar conjugative plasmids and belonged to two distinct genetic lineages. A synergy test with ceftazidime and imipenem enabled us to identify five unrelated bla(IBC-1)-carrying E. cloacae isolates from other wards of the hospital. It seems that this integron-associated gene is capable of dispersing both by clonal spread and by gene dissemination.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Ceftazidime / pharmacology
  • Cephalosporin Resistance
  • Disease Outbreaks*
  • Enterobacter cloacae / drug effects
  • Enterobacter cloacae / enzymology*
  • Enterobacter cloacae / genetics
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / microbiology
  • Greece / epidemiology
  • Hospitals, University
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Integrases / genetics
  • Intensive Care, Neonatal*
  • Microbial Sensitivity Tests
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Ceftazidime
  • Integrases
  • integron integrase IntI1
  • integron-associated beta-lactamase 1
  • beta-Lactamases